A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib
Condition(s):Hyperglycemia Drug InducedLast Updated:June 11, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Hyperglycemia Drug InducedLast Updated:June 11, 2021Terminated
Condition(s):Hyperglycemia Drug InducedLast Updated:November 17, 2021Recruiting
Condition(s):Type 2 Diabetes; Glucose Tolerance Impaired; Insulin SensitivityLast Updated:December 23, 2021Recruiting
Condition(s):Type 1 Diabetes Mellitus; DiabetesLast Updated:February 7, 2017Completed
Condition(s):Type1 Diabetes MellitusLast Updated:April 5, 2021Completed
Condition(s):Type 2 Diabetes Mellitus; DiabetesLast Updated:April 10, 2018Completed
Condition(s):Type 1 Diabetes MellitusLast Updated:March 31, 2022Active, not recruiting
Condition(s):Type 1 DiabetesLast Updated:September 28, 2021Recruiting
Condition(s):Type 1 DiabetesLast Updated:March 31, 2022Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.